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INTRODUCTION
Respiratory mucus secretion is essential for protecting the lungs 
and airway tracts from external environment, chemicals, and 
microorganisms. However, mucus secretion is abnormally aug-
mented in disease states, such as chronic bronchitis, asthma, cys-
tic fibrosis, and chronic rhinosinusitis, which lead to an increase 
in the morbidity and mortality of the affected patients (1, 2). 
The predominant mucins present in inflammatory airway dis-
ease are MUC4, MUC5AC, and MUC5B, which are regulated 
by many pathophysiological mediators and hormones (3).
  Among the pathophysiological mediators of mucin secretion, 
matrix metalloproteinases (MMPs) play a critical role in the 
maintenance and turnover of extracellular matrix macromole-
cules. MMPs are associated with inflammatory airway diseases 
such as asthma, chronic obstructive pulmonary disease, and id-
iopathic pulmonary fibrosis. Especially, in inflammatory airway 
disease, the predominant form of MMPs is MMP-9 (4-6). How-
ever, the precise role and function of MMP-9 with regard to mu-
cin secretion in inflammatory airway disease remains unknown.
  Phorbol 12-myristate 13-acetate (PMA), a protein kinase C 
(PKC) activator, has been used as an inflammatory stimulant 
that can modulate a variety of cellular events including gene 
transcription, cell growth, and differentiation (7). PMA also 
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stimulates MMP-9 expression in various cancer cells, and MUC2 
and MUC5B expression in airway and intestinal epithelial cells 
(7-10).
  Doxycycline, a long-acting semisynthetic tetracycline, is com-
monly used in medical fields because of its safety and efficacy 
as a bacteriostatic antimicrobial agent. In addition to these ef-
fects, recent studies have demonstrated that doxycyline has both 
intracellular and extracellular anti-inflammatory effects (11, 12). 
However, the effects of doxycycline on mucin secretion in in-
flammatory airway disease have not been clearly defined.
  Therefore, the goal of this study was to determine whether 
doxycycline might play an important role in mucin secretion of 
the inflammatory airway epithelial cells. In this study, the effects 
and signal pathways of doxycycline on PMA-induced MUC5B 
expression dependent MMP-9 in human airway epithelial cells 
were investigated.
MATERIALS AND METHODS
Cell culture and treatment
The mucin-producing human NCI-H292 airway epithelial cells 
were obtained from the American Type Culture Collection 
(Manassas, VA, USA). The cells were cultured in RPMI 1640 me-
dium (Invitrogen, Carlsbad, CA, USA) supplemented with 2 
mM L-glutamine, 100 U/mL penicillin, 100 μg/mL streptomy-
cin, and 10% fetal bovine serum (FBS; Hyclone Laboratories 
Inc., Logan, UT, USA). The cells were grown at 37°C in 5% CO2 
fully humidified air, and were subcultured twice weekly. The cells 
were seeded in a 6-well plate at 1×10
5 cells/well. When the cul-
tured cells were in a confluent state, the cultured cells were in-
cubated in RPMI 1640 medium containing 0.5% FBS for 24 
hours. The cultured cells were then rinsed with serum-free RPMI 
1640 medium and exposed to the indicated concentrations of 
PMA (Sigma, St. Louis, MO, USA), MMP-9 (R&D Systems Inc., 
Minneapolis, MN, USA), and doxycycline (Sigma). In order to 
investigate the signaling pathway of PMA-induced MUC5B ex-
pression, SB2035 (BOMOL Research Laboratories, Plymouth 
Meeting, PA, USA), as specific inhibitors, was used to pretreat 
the human NCI-H292 airway epithelial cells for 1 hour before 
exposure to the indicated concentrations of PMA. In the case of 
the controls, the cultured cells were incubated with medium 
alone for the same amount of time.
Reverse transcription-polymerase chain reaction (RT-PCR) 
analysis of MUC5B and MMP-9mRNA expression
The total RNAs from PMA treated the cultured cells were pre-
pared using the available reagent (TRIzol; Invitrogen) according 
to the manufacturer’s instructions. Fifteen micrograms of the 
RNA were reverse-transcribed into cDNA at 37°C for 70 min-
utes in 60 μL volume of reaction mixture that contained 150 U 
of reverse-transcriptase (Superscript-II; Invitrogen), 10 mM each 
of dATP, dTTP, dCTP, and dGTP, and 5 μL of 50 μM Oligo-dT 
primer/mL (Amersham International PLC, Little Chalfont, Buck-
inghamshire, UK). The reactions were stopped by heat inactiva-
tion at 85°C for 10 minutes. Two microliters of each cDNA sam-
ple, from the reverse transcription, were amplified by PCR (PTC-
200, MJ Research Inc., Watertown, MA, USA) in a volume of 50 
μL that contained 0.5 U of Taq DNA polymerase, 2 μL of 50 mM 
MgCl2, 1 μL each 0f 10 mM dATP, dTTP, dCTP, and dGTP, and 
1 μL of the 10 μM primers. The PCR of glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) was performed on each indi-
vidual sample as a positive internal control. The primer sequenc-
es used in the PCR were 5′-CAC ATC CAC CCT TCC AAC-3′ 
(sense) and 5′-GGC TCA TTG TCG TCT CTG-3′ (antisense) for 
MUC5B (245 bp), and 5′-CCT CCA AGG AGT AAG ACC CC-
3′ (sense) and 5′-AGG GGT CTA CAT GGC AAC TG-3′ (anti-
sense) for GAPDH (145 bp). After a hot start, the amplification 
profile was 30 cycles for 1 minute of denaturation at 95°C, 30 
seconds of annealing at 60°C, and 1 minute of extension at 
72°C in the presence of 2.5 mg MgCl2 for MUC5B and MMP-9. 
The PCR products were electrophoresed on a 2% agarose gel, 
stained with ethidium bromide, and visualized by UV fluores-
cence. Semiquantitative analysis of the RT-PCR product was 
performed on the scanned gel images, and the intensity of the 
PCR product was measured using commercially available imag-
ing software (Scion Software; Scion Co., Frederick, MD, USA). 
The relative intensity of the individual bands on the gel image 
was determined as the ratio of the intensities of MUC5B and 
MMP-9 to the intensity of GAPDH.
Enzyme-linked immunosorbent assay (ELISA) analysis of 
MUC5B protein
MUC5B protein was determined by ELISA. Samples of the su-
pernatant or cell lysates from the cultured cells were prepared 
in phosphate-buffered saline (PBS) at several dilutions, and each 
sample was incubated at 40°C in a 96-well plate until dry. The 
plates were then washed three times with PBS, blocked with 2% 
bovine serum albumin for 1 hour at room temperature, washed 
again three times with PBS, and incubated with primary anti-
body of MUC5B (Santa Cruz Biotechnology, Santa Cruz, CA, 
USA) diluted with PBS containing 0.05% Tween 20 for 1 hour. 
The wells were then washed three times with PBS and treated 
with horseradish peroxidase-conjugated secondary antibody of 
MUC5B (Santa Cruz Biotechnology). After 4 hours, the plates 
were washed three times with PBS. Color was developed using 
3,3′,5,5′-tetramethylbenzidine peroxidase solution and stopped 
with 2N-H2SO4. The absorbance was read at 450 nm.
Gelatin zymography assay analysis of MMP-9 protein activity
MMP-9 protein activity was measured by gelatin zymography. 
In brief, the cells culture supernatants containing 10 μg of pro-
tein were mixed with 2×sodium-dodecyl sulfate loading buffer 
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containing 0.1% (wt/vol) gelatin as a substrate (Biotech, Piscat-
away, NJ, USA). The protein was subjected to electrophoresis at 
80 volt for 120 minutes and the gel was then washed twice with 
zymogram renaturing solution (Biotech) for 45 minutes at room 
temperature. The gel was preincubated in zymogram developing 
solution (Biotech) for 30 minutes at 37°C and subsequently in-
cubated in zymogram developing solution for 24 hours at 37°C. 
After incubation, the gel was stained by 0.5% Coomassie Blue 
R-250 (Bio-Rad Laboratories, Hercules, CA, USA) in 30% 
methanol and 5% acetic acid solution under continuous shaking 
for 2 hours, then de-stained in 30% methanol and 5% acetic 
acid solution for 30 minutes, and then rinsed twice with de-
staining solution to visualize the digested bands in the gelatin 
matrix. The gels were photographed and the averages of the 
band intensity were measured using commercially available im-
aging software (Scion Software).
Western blot analysis of extracellular signal-regulated kinase 
1/2 (ERK1/2) and p38 phosphorylation
The cultured cells were seeded in a 6-well plate and treated with 
PMA and/or MMP-9, and doxycycline for the indicated times. 
The cells were then washed with cold PBS, exposed to trypsin, 
and formed into pellets at 700 g at 4°C. The pellets were resus-
pended in lysis buffer (50 mM Tris-HCl, pH 8.0, 5 mM EDTA, 
150 mM NaCl, 1% Triton X-100, 1 mM phenylmethylsulfonyl 
fluoride, and protease inhibitor cocktail). The preparation was 
then clarified by centrifugation, and the supernatant was saved 
as a whole-cell lysate. The proteins (50 μg) were separated using 
10% reducing SDS-polyacrylamide gel electrophoresis and elec-
troblotted in 20% methanol, 25 mM Tris, and 192 mM glycine 
onto a nitrocellulose membrane. The membrane was then block-
ed with 5% nonfat dry milk in 25 mM Tris-HCl, 150 mM NaCl, 
and 0.2% Tween 20, and then incubated with the indicated pri-
mary antibody of ERK1/2 (Santa Cruz Biotechnology) or p38 
(Santa Cruz Biotechnology) for 4 hours. Subsequently, the mem-
brane was washed and incubated for 1 hour with secondary an-
tibody of ERK1/2 (Santa Cruz Biotechnology) or p38 (Santa 
Cruz Biotechnology) conjugated to HRP, rewashed, and devel-
oped using an enhanced chemiluminescence reagent kit (Perki-
nElmer Life Sciences, Boston, MA, USA) and exposed to X-ray 
film for 10 seconds.
Cell transfection with small interfering RNA (siRNA) for p38 
mitogen-activated protein kinase (MAPK)
Predesigned siRNA targeting p38 MAPK and negative control 
siRNA for p38 MAPK were purchased from Invitrogen (Carls-
bad, CA, USA). The sequences of p38 MAPK siRNA were as 
follows; sense: AUG AAU GAU GGA CUG AAA UGG UCU G 
and antisense: CAG ACC AUU UCA GUC CAU CAU UCA U. 
The transfection rate of p38 MAPK siRNA was verified to be 
over 90% in the human NCI-H292 airway epithelial cells. 
Transfection was performed according to the manufacture’s pro-
tocol (Invitrogen). In brief, the human NCI-H292 airway epithe-
lial cells were seeded in a 6-well plate at 1×10
5 cells/well and 
incubated overnight in RPMI 1640 medium without antibiotics. 
When the cells were 80-90% confluent, the following day, and 
the cells were washed with PBS, and then OPTI-MEN I Re-
duced Serum Medium (Invitrogen) was added to the cells. Then, 
p38 MAPK siRNA and a nucleic acid transferring agent, Lipo-
fectamine 2000 (Invitrogen) was incubated together in OPTI-
MEM I Reduced Serum Medium for 20 minutes at room tem-
perature to form a p38 MAPK siRNA-Lipofectamine complex. 
The p38 MAPK siRNA-Lipofectamine complex-containing me-
dium was added to each well containing the cells to a final p38 
MAPK siRNA concentration of 20 nM; the cells were then incu-
bated for 24 hours at 37°C in a CO2 incubator. The p38 MAPK 
siRNA-Lipofectamine complex-containing medium was re-
placed with RPMI 1640 medium after 4 hours without loss of 
transfection activity. After 24 hours of transfection with p38 
MAPK siRNA, the cells were exposed to the indicated concen-
trations of PMA and then harvested for RT-PCR analysis of 
MUC5B mRNA expression. The same procedure was performed 
with a negative control siRNA (Invitrogen).
Statistical analysis
Statistical analysis was performed using SPSS ver. 10.0 (SPSS 
Inc., Chicago, IL, USA). The mean for each of the obtained 
quantitative values was calculated. Comparisons were made us-
ing the Student’s t-test. For all tests, a P-value of less than 0.05 
was considered statistically significant.
RESULTS
Effect of PMA on MUC5B and MMP-9 mRNA expression
The effects of PMA on MUC5B and MMP-9 mRNA expression 
in a dose-dependent manner were investigated. The MUC5B 
mRNA expression was significantly increased at all doses of 
PMA and peaked to 10 nM of PMA for 8 hours, and the MMP-
9 mRNA expression was significantly increased about 17 fold at 
5, 10, 25, and 50 nM for 8 hours (P<0.05) (Fig. 1).
Effect of MMP-9 on MUC5B mRNA expression
The effect of MMP-9 on MUC5B mRNA expression in a dose-
dependent manner was investigated. MUC5B mRNA expression 
was significantly increased in a dose-dependent manner (P<
0.05) (Fig. 2).
Phosphorylation of p38 in PMA-induced MUC5B expression
SB203580 as a p38 MAPK inhibitor inhibited the PMA-induced 
MUC5B expression (P<0.05) (Fig. 3A). In addition, the knock-
down of p38 MAPK by p38 MAPK siRNA significantly blocked 
PMA-induced MUC5B mRNA expression (P<0.05) (Fig. 3B).180    Clinical and Experimental Otorhinolaryngology   Vol. 4, No. 4: 177-183, December 2011
Phosphorylation of ERK1/2 and p38 in the effect of doxycy-
cline after treatment with PMA or MMP-9
Doxycycline inhibited PMA induced phosphorylation of p38 in 
a dose dependent manner; however, it did not change the phos-
phorylation of ERK1/2 significantly (P<0.05) (Fig. 6A). In addi-
tion, doxycyline significantly inhibited MMP-9 induced phos-
phorylation of p38 (P<0.05) (Fig. 6B). 
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Fig. 1. The effect of phorbol 12-myristate 13-acetate (PMA) on MUC5B 
and matrix metalloproteinase (MMP)-9 mRNA expression. Human 
NCI-H292 airway epithelial cells were stimulated with PMA. MUC5B 
and MMP-9 mRNA levels were analyzed by RT-PCR. MUC5B mRNA 
express ion was significantly increased at all doses of PMA and 
peaked at 10 nM of PMA. MMP-9 mRNA expression was significantly 
increased about 17 fold at 5, 10, 25, and 50 nM of PMA. *P<0.05 
compared with zero value.
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Fig. 2. The effect of matrix metalloproteinase (MMP)-9 on MUC5B 
mRNA expression. Human NCI-H292 airway epithelial cells were 
stimulated with MMP-9. MUC5B mRNA levels were analyzed by RT-
PCR. MUC5B mRNA expression was significantly increased in a 
dose-dependent manner. *P<0.05 compared with zero value.
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Fig. 3. The effect of SB203580 and p38 MAPK siRNA on the phosphorylation of p38 MAPK in phorbol 12-myristate 13-acetate (PMA)-induced 
MUC5B mRNA expression. Human NCI-H292 airway epithelial cells were stimulated with SB203580 before exposure to PMA, and also were 
transfected with predesigned siRNA targeting p38 MAPK and a negative control siRNA for p38 MAPK before exposure to PMA. MUC5B mRNA 
expression was analyzed by RT-PCR. (A) SB203580 inhibited PMA-induced MUC5B expression. (B) The knockdown of p38 MAPK by p38 
MAPK siRNA significantly blocked PMA-induced MUC5B mRNA expression. *P<0.05 compared with PMA alone. **P<0.05 compared with 
control.
A B
Effect of doxycycline on PMA-induced MUC5B expression and 
PMA-induced MMP-9 mRNA expression and protein activity
Doxycycline significantly inhibited PMA-induced MUC5B ex-
pression in a dose-independent manner (P<0.05) (Fig. 4). Doxy-
cycline significantly inhibited PMA-induced MMP-9 mRNA ex-
pression (P<0.05) (Fig. 5A). In addition, doxycycline significant-
ly inhibited PMA-induced MMP-9 protein activity (P<0.05) 
(Fig. 5B).Bae CH et al.: Doxycycline Inhibits PMA-Induced MUC5B Expression    181
DISCUSSION
MUC5B is located on chromosome 11p15.5, and induce the ma-
jor gel-forming mucin that plays an important role in the protec-
tion and lubrication of the epithelial surface of the normal hu-
man airway (13). MUC5B also induce mucin secretion in chronic 
bronchitis and cystic fibrosis by a variety of inflammatory media-
tors such as bacterial lipopolysaccharide (LPS), interleukin-1β, 
tumor necrosis factor-α and leukotriene D4 (3, 14-16).
  PMA is a PKC activator, and is used as a model inflammatory 
mediator that can modulate gene transcription, cell growth, and 
differentiation of cells (7). PMA is also known to stimulate the 
expression of MUC2 and MUC5B in the airway and intestinal 
epithelial cells, and the expression of MMP-9 in the airway and 
intestinal epithelial cells. And the p38 MAPK pathways are gen-
erally activated by stress related conditions, in various airway 
diseases, and are also involved in the regulation of PMA-in-
duced MUC5B expression (7-10). Therefore, this study focused 
on MUC5B expression and p38 MAPK pathways in the effects 
and signal pathways of doxycycline on PMA-induced mucin se-
cretion.
  MMP-9 plays an important role in the regulation of extracel-
lular matrix macromolecules, and is associated with persistent 
mucin production in human airway cells, and the regulation of 
MUC2 expression in the goblet cell of the colon (17, 18).
  The precise mechanisms, associated with the regulation of the 
mucin gene for PMA and MMP-9, are unknown, but several 
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Fig. 4. The effect of doxycycline on phorbol 12-myristate 13-acetate 
(PMA)-induced MUC5B expression. Human NCI-H292 airway epi-
thelial cells were stimulated with doxycycline after the treatment of 
PMA. MUC5B RNA levels were analyzed by RT-PCR, and MUC5B 
protein levels of cell lysates and supernatants were analyzed by en-
zyme-linked immunosorbent assay (ELISA). Doxycycline significant-
ly inhibited PMA-induced MUC5B mRNA expression and protein 
production in a dose-dependent manner. *P<0.05 compared with 
PMA alone.
Fig. 5. The effect of doxycycline on phorbol 12-myristate 13-acetate 
(PMA)-induced matrix metalloproteinase (MMP)-9 mRNA expression 
and protein activity. Human NCI-H292 airway epithelial cells were 
stimulated with doxycycline after treatment with PMA. MMP-9 mRNA 
levels were analyzed by RT-PCR, and MMP-9 protein activity was 
measured by gelatin zymography. (A) Doxycycline significantly in-
hibited PMA-induced MMP-9 mRNA expression. (B) Doxycycline 
significantly inhibited PMA-induced MMP-9 protein activity. *P<0.05 
compared with PMA alone.
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studies have reported that PMA induced MMPs expression, and 
then PMA-induced MMPs cause mucin gene expression through 
Sp1-dependent mechanisms (7, 19). In this study, PMA in-
creased MUC5B and MMP-9 mRNA expression, and MMP-9 
increased MUC5B mRNA expression in human NCI-H292 air-
way epithelial cells. These results suggest that MMP-9 may be an 
important mediator of MUC5B expression, and that PMA in-
creases MUC5B expression through MMP-9.
  Doxycycline, a member of the tetracycline family, has a bac-
teriostatic antimicrobial effect with inhibition of inflammation, 
angiogenesis and apoptosis (11, 12). In addition, doxycycline in-
hibits MMP activity, and leads to the prevention of extracellular 
matrix component breakdown in various cells such as human 
endothelial cells, skin keratinocytes, and corneal epithelial cells 
(11). Recently, several studies have shown that doxycycline in-
hibits LPS-induced MMP-9 expression and LPS-induced MU-
C5AC expression in airway epithelial cells (20), and inhibits 
transforming growth factor-β1-induced MMP-9 expression in 
human corneal epithelial cells (12), and inhibits acrolein-in-
duced MMP-9 and MUC5AC expression in tracheal epithelium 
(21). However, the effects of doxycycline on mucin secretion in 
inflammatory airway disease have not been clearly defined. The 
results of this study demonstrated that doxycycline inhibited 
PMA-induced MUC5B expression, and inhibited PMA-induced 
MMP-9 mRNA expression and protein activity. In addition, 
doxycycline inhibited PMA and MMP-9 induced-phosphoryla-
tion of p38; SB203580 (p38 MAPK inhibitor) inhibited PMA-
induced MUC5B mRNA expression. In addition, the knock-
down of p38 MAPK by p38 MAPK siRNA significantly blocked 
PMA-induced MUC5B mRNA expression, and the knockdown 
of p38 MAPK by p38 MAPK siRNA significantly blocked PMA-
induced MUC5B mRNA expression. While a study has reported 
that the high concentration of PMA (50 ng/mL) induced phos-
phorylation of ERK1/2 in human NCI-H292 airway epithelial 
cells (22), the results of this study suggest that doxycycline in-
hibits MUC5B expression through inhibitory action on MMP-9 
expression, and p38 plays a role in the signal pathway of down-
regulation of MUC5B by doxycycline in inflammatory airway 
disease. However, the effects of doxycycline on other mucins 
and the precise signal pathways for the regulation of the mucin 
gene by doxycycline in the airway epithelial cells require further 
confirmation.
  In conclusion, the results of this study suggest that doxycy-
cline inhibits PMA-induced MUC5B expression through the 
MMP-9 and p38 pathways in human NCI-H292 airway epithe-
lial cells. These findings provide information that doxycycline 
may play a role in the control of mucus hypersecreation through 
MMP-9 and p38 pathways in human airway epithelial cells.
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Fig. 6. The effects of doxycycline on the phosphorylation of ERK1/2 and p38 after treatment with phorbol 12-myristate 13-acetate (PMA) or ma-
trix metalloproteinase (MMP)-9. Human NCI-H292 airway epithelial cells were stimulated with doxycycline after treatment with PMA or MMP-9. 
The phosphorylation of ERK1/2 and p38 were detected by Western blot analysis. (A) Doxycycline inhibited PMA induced phosphorylation of 
p38 in a dose dependent manner, but it did not change the phosphorylation of ERK1/2 significantly. (B) Doxycycline significantly inhibited MMP-
9 induced phosphorylation of p38. *P<0.05 compared with PMA alone.
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